Altium Capital Management’s Insmed INSM Stock Holding History

Altium Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-132,000	Closed	-$9.11M	–	48
2024 Q4	$9.11M	Buy	132,000 +2,000	+2%	+$144K	2.58%	15
2024 Q3	$9.49M	Sell	130,000 -60,000	-32%	-$4.43M	2.79%	10
2024 Q2	$12.7M	Buy	190,000 +70,000	+58%	+$2.71M	5.19%	6
2024 Q1	$3.26M	Hold	120,000	–	–	1.29%	26
2023 Q4	$3.72M	Buy	+120,000	New	+$3.11M	2.52%	15
2022 Q4	–	Sell	-268,000	Closed	-$5.77M	–	113
2022 Q3	$5.77M	Hold	268,000	–	–	2.12%	7
2022 Q2	$5.29M	Hold	268,000	–	–	2.11%	8
2022 Q1	$6.3M	Buy	268,000 +64,646	+32%	+$1.5M	2.11%	9
2021 Q4	$5.54M	Hold	203,354	–	–	1.53%	16
2021 Q3	$5.6M	Hold	203,354	–	–	1.47%	20
2021 Q2	$5.79M	Buy	203,354 +93,100	+84%	+$2.76M	1.34%	20
2021 Q1	$3.75M	Sell	110,254 -38,489	-26%	-$1.47M	1.04%	35
2020 Q4	$4.95M	Buy	+148,743	New	+$5.43M	1.85%	12

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Altium Capital Management's INSM Position: Q1 2025 in Review

Altium Capital Management sold out of Insmed (INSM) in Q1 2025, closing a stake of 132,000 shares — an estimated $9.11M sold.

Altium Capital Management first reported a position in INSM in Q4 2020 and held it in 13 quarters. The position peaked at $12.7M in Q2 2024. 441 funds tracked by Wall St. Rank hold INSM as of Q1 2025.

Altium Capital Management reported no remaining Insmed position as of Q1 2025 after selling out during the quarter.
Altium Capital Management sold 132,000 Insmed shares in Q1 2025, an estimated $9.11M.
Altium Capital Management first reported a position in Insmed in Q4 2020 and held it in 13 quarters.
Altium Capital Management's Insmed position peaked at $12.7M in Q2 2024.
441 funds tracked by Wall St. Rank held Insmed as of Q1 2025.

Based on Altium Capital Management's 13F filing for Q1 2025, filed 9 May 2025.